Concepedia

Qinglin Pu

QP

Statistics

Publications

11

Citations

332

H-Index

10

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

WuXi AppTec (China)

University of New Hampshire

Qinglin Pu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in natural sciences, drug development, and medicine.

ORCID

Top concepts

Publications per year

1992–2022

11

Publications

11

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

A New Class of Alkaloids from a Dendrobatid Poison Frog: A Structure for Alkaloid 251F

T. F. SPANDE, H. Martin Garraffo, Herman J. C. Yeh et al. · Journal of Natural Products · 1992 · 61 citations

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

Hongjun Zhang, K. Liu, Qinglin Pu et al. · ACS Medicinal Chemistry Letters · 2019 · 44 citations · Full text

Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors

Derun Li, Yongqi Deng, Abdelghani Achab et al. · ACS Medicinal Chemistry Letters · 2021 · 25 citations · Full text

Preparation of conductive polyaniline‐sulfonated EPDM ionomer composites from <i>in situ</i> emulsion polymerization and study of their properties

Hong‐Quan Xie, Qinglin Pu, Dong Xie · Journal of Applied Polymer Science · 2004 · 22 citations

, , +17

1–5 of 11